Almost 15 years ago, scientists and clinicians set out to characterize genomes of tumours from thousands of patients. The result? The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC). Nearly every targeted cancer drug approved over the past decade has drawn from the data sets generated by […]